{"filing":{"accession_number":"0001477932-26-005329","cik":"0001187953","ticker":"CELZ","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","form":"8-K","filing_date":"2026-08-31","report_date":"2026-08-28","primary_document":"celz_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1187953/000147793226005329/celz_8k.htm"},"events":[{"id":30597,"run_id":28048,"accession_number":"0001477932-26-005329","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Shareholders approved two proposals at a Special Meeting held on August 28, 2026: (i) an amendment to increase authorized common shares from 25 million to 100 million shares, and (ii) approval of the exercise of 5.58 million investor warrants from a June 2026 private placement. Both proposals passed with 65.4% of outstanding shares represented.","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","filing_date":"2026-08-31","form":"8-K","submitted_at":null,"items":[{"id":33239,"accession_number":"0001477932-26-005329","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure reports a stockholder-approved amendment to the Articles of Incorporation increasing authorized common shares from 25 million to 100 million. While a governance matter, this is a routine administrative amendment that does not itself create a material financial obligation, executive change, or strategic event. The increase in authorized shares is a procedural step that enables future issuances but does not constitute a material event affecting the total mix of information available to investors absent accompanying dilutive issuance or capital-raising activity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:11:57.945209+00:00","company_name":"","ticker":null,"filing_date":""},{"id":33240,"accession_number":"0001477932-26-005329","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from a Special Meeting held on August 28, 2026. The filing reports voting outcomes on two proposals: (i) approval of an amendment to increase authorized common shares from 25 million to 100 million shares, and (ii) approval of the exercise of 5.58 million investor warrants from a June 2026 private placement. Both proposals passed. The disclosure includes vote tallies (For, Against, Abstain, Broker Non-Votes) and quorum information (65.4% of outstanding shares represented), which are the hallmarks of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:11:57.945209+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33239,"accession_number":"0001477932-26-005329","item_number":"5.03","item_title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.85,"reasoning":"This disclosure reports a stockholder-approved amendment to the Articles of Incorporation increasing authorized common shares from 25 million to 100 million. While a governance matter, this is a routine administrative amendment that does not itself create a material financial obligation, executive change, or strategic event. The increase in authorized shares is a procedural step that enables future issuances but does not constitute a material event affecting the total mix of information available to investors absent accompanying dilutive issuance or capital-raising activity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:11:57.945209+00:00","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","filing_date":"2026-08-31"},{"id":33240,"accession_number":"0001477932-26-005329","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from a Special Meeting held on August 28, 2026. The filing reports voting outcomes on two proposals: (i) approval of an amendment to increase authorized common shares from 25 million to 100 million shares, and (ii) approval of the exercise of 5.58 million investor warrants from a June 2026 private placement. Both proposals passed. The disclosure includes vote tallies (For, Against, Abstain, Broker Non-Votes) and quorum information (65.4% of outstanding shares represented), which are the hallmarks of Item 5.07 shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T20:11:57.945209+00:00","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","ticker":"CELZ","filing_date":"2026-08-31"}]}